LYRM3 Antibody

ProSci
Product Code: PSI-5663
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-5663-0.02mg0.02mg£150.00
Quantity:
PSI-5663-0.1mg0.1mg£449.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunofluorescence (IF)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)

Images

1 / 3
Western blot analysis of LYRM3 in human liver tissue lysate with LYRM3 antibody at (A) 1 and (B) 2 μg/mL.
2 / 3
Immunohistochemistry of LYRM3 in rat liver tissue with LYRM3 antibody at 5 μg/mL.
3 / 3
Immunofluorescence of LYRM3 in rat liver tissue with LYRM3 antibody at 20 μg/mL.

Western blot analysis of LYRM3 in human liver tissue lysate with LYRM3 antibody at (A) 1 and (B) 2 μg/mL.
Immunohistochemistry of LYRM3 in rat liver tissue with LYRM3 antibody at 5 μg/mL.
Immunofluorescence of LYRM3 in rat liver tissue with LYRM3 antibody at 20 μg/mL.

Further Information

Additional Names:
LYRM3 Antibody: B22, LYRM3, CI-B22, UQOR22, Complex I-B22
Application Note:
LYRM3 antibody can be used for detection of LYRM3 by Western blot at 1 - 2 μg/mL. Antibody can also be used for immunohistochemistry starting at 5 μg/mL. For immunofluorescence start at 20 μg/mL.

Antibody validated: Western Blot in human samples; Immunohistochemistry in rat samples and Immunofluorescence in rat samples. All other applications and species not yet tested.
Background:
LYRM3 Antibody: LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.
Background References:
  • Lin X, Wells DE, Kimberling WJ, et al. Human NDUFB9 gene: genomic organization and a possible candidate gene associated with deafness disorder mapped to chromosome 8q13. Hum. Heredity1999; 49:75-80.
Buffer:
LYRM3 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Homology:
Predicted species reactivity based on immunogen sequence: Bovine: (94%)
Immunogen:
LYRM3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human LYRM3.

The immunogen is located within the last 50 amino acids of LYRM3.
NCBI Gene ID #:
4715
NCBI Official Name:
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa
NCBI Official Symbol:
NDUFB9
NCBI Organism:
Homo sapiens
Physical State:
Liquid
Protein Accession #:
Q9Y6M9
Protein GI Number:
8134589
Purification:
LYRM3 Antibody is affinity chromatography purified via peptide column.
Research Area:
Homeostasis
Swissprot #:
Q9Y6M9
User NOte:
Optimal dilutions for each application to be determined by the researcher.

Related Products

Product NameProduct CodeSupplier 
LYRM3 PeptidePSI-5663PProSci Summary Details